ConductScience.org, home

Gene · 252995

Papers4,118

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

461 to 480 of 4,118

Download this page as JSON
TitleJournalYearPMIDFound bySource
Predictive value of osteopenia as prognostic marker for survival and recurrence in patients with gastrointestinal cancers: a systematic review and meta-analysis.Front Med (Lausanne)202540375934PubTator, text miningPubMed
Role and mechanisms of exercise therapy in enhancing drug treatment for glioma: a review.Front Immunol202540370453PubTator, text miningPubMed
Food-derived polysaccharides and anti-obesity effects through enhancing adipose thermogenesis: structure-activity relationships, mechanisms, and regulation of gut microecology.Crit Rev Food Sci Nutr202540351151PubTator, text miningPubMed
Understanding myokine Irisin's function in oral cancer: therapeutic and prognostic consequences.Expert Rev Anticancer Ther202540338275PubTator, text miningPubMed
Myokines and interorgan crosstalk: bridging exercise to health promotion and disease prevention.Ann Pediatr Endocrinol Metab202540335041PubTator, text miningPubMed
From Skeletal Muscle to Myocardium: Molecular Mechanisms of Exercise-Induced Irisin Regulation of Cardiac Fibrosis.Int J Mol Sci202540332022PubTator, text miningPubMed
An investigation of serum irisin levels and inflammatory markers in fibromyalgia syndrome.North Clin Istanb202540330525PubTator, text miningPubMed
[Nutritional impact of beta-hydroxy-β-methylbutyrate supplementation in patients undergoing bariatric surgery].Nutr Hosp202540326309PubTator, text miningPubMed
Are breast milk and serum irisin levels affected by the BMI and nutritional status? A prospective observational study.Eur J Pediatr202540325267PubTator, text miningPubMed
The effect of esketamine on postoperative anxiety and depression in patients with thyroid cancer: A randomized, double-blind, placebo-controlled, parallel-group trial.Medicine (Baltimore)202540324271PubTator, text miningPubMed
Irisin Is a Potential Novel Biomarker and Therapeutic Target Against Kidney Diseases.Cell Biochem Funct202540318104PubTator, text miningPubMed
The malignant signature gene of cancer-associated fibroblasts serves as a potential prognostic biomarker for colon adenocarcinoma patients.Front Immunol202540313961PubTator, text miningPubMed
Irisin in the modulation of bone and cartilage homeostasis: a review on osteoarthritis relief potential.Front Physiol202540313878PubTator, text miningPubMed
The investigation of resting-state functional connectivity in male sprinters and endurance runners brains based on fNIRS.Sci Rep202540301539PubTator, text miningPubMed
Serum Levels of Irisin Are Positively Associated with Improved Cardiac Function in Patients with Heart Failure with Reduced Ejection Fraction.Biomedicines202540299414PubTator, text miningPubMed
High Serum Levels of Irisin, Visfatin and Adiponectin as Potential Independent Risk Factors for Diabetic Nephropathy Progression in Patients With Type 2 Diabetes Mellitus.In Vivo202540294981PubTator, text miningPubMed
Evaluation of adipokines, oxidative stress, and inflammatory markers in gout patients.Arch Rheumatol202540264479PubTator, text miningPubMed
Correction to: Irisin: muscle's novel player in endoplasmic reticulum stress and disease.Mol Cell Biochem202540257721PubTator, text miningPubMed
Role of molecular hydrogen in obesity treatment: modulation of GLP-1, irisin, and PGC-1α for improved metabolism.Med Gas Res202540251025PubTator, text miningPubMed
Cytokine response to resistance exercise in children with excess adiposity and Prader-Willi syndrome.Physiol Rep202540243109PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/252995/papers?page=24